Polymeric Prodrugs Containing Metal-Based Anticancer Drugs

被引:0
|
作者
B. A. Aderibigbe
机构
[1] University of Fort Hare,Department of Chemistry
[2] Alice Campus,undefined
关键词
Anticancer; Metal complexes; Prodrugs; Medicinal organometallics;
D O I
暂无
中图分类号
学科分类号
摘要
Prodrugs optimize the absorption, distribution, metabolism, excretion and reduce unwanted toxicity of the parent drugs. The medicinal application of polymeric prodrugs for delivery of metal-based anticancer drugs is a field of increasing prominence because metal-based drugs offer possibilities for the design of therapeutic agents that are not readily available to organic compounds. This review is focused on the progress of polymeric prodrugs of metal based anticancer agents. A better understanding of the pharmacokinetics of these prodrugs will provide a rational for their further development into anticancer drugs for overcoming multidrug resistance.
引用
收藏
页码:339 / 353
页数:14
相关论文
共 50 条
  • [1] Polymeric Prodrugs Containing Metal-Based Anticancer Drugs
    Aderibigbe, B. A.
    [J]. JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS, 2015, 25 (03) : 339 - 353
  • [2] Transition Metal-Based Prodrugs for Anticancer Drug Delivery
    Phillips, Ana M. F.
    Pombeiro, Armando J. L.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2019, 26 (41) : 7476 - 7519
  • [3] Gold complexes as prospective metal-based anticancer drugs
    Milacic, V.
    Fregona, D.
    Dou, Q. P.
    [J]. HISTOLOGY AND HISTOPATHOLOGY, 2008, 23 (01) : 101 - 108
  • [4] A New Look into the Mode of Action of Metal-Based Anticancer Drugs
    Marques, M. Paula M.
    de Carvalho, Ana L. M. Batista
    Mamede, Adriana P.
    Dopplapudi, Asha
    Rudic, Svemir
    Tyagi, Madhusudan
    Sakai, Victoria Garcia
    Batista de Carvalho, Luis A. E.
    [J]. MOLECULES, 2020, 25 (02):
  • [5] Electron-transfer activated metal-based anticancer drugs
    Reisner, Erwin
    Arion, Vladimir B.
    Keppler, Bernhard K.
    Pombeiro, Armando J. L.
    [J]. INORGANICA CHIMICA ACTA, 2008, 361 (06) : 1569 - 1583
  • [6] Supramolecular Delivery Systems for NonPlatinum Metal-Based Anticancer Drugs
    Ringhieri, Paola
    Morelli, Giancarlo
    Accardo, Antonella
    [J]. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2017, 34 (02): : 149 - 183
  • [7] New Strategies and Trends for the Design of Metal-Based Anticancer Drugs
    Wang Xiaoyong
    Guo Zijian
    [J]. PROGRESS IN CHEMISTRY, 2009, 21 (05) : 845 - 855
  • [8] Engineered flavoproteins as bioorthogonal photo-triggers for the activation of metal-based anticancer prodrugs
    Mazzei, Laura F.
    Gurruchaga-Pereda, Juan
    Martinez, Alvaro
    Martinez, Javier Calvo
    Salassa, Luca
    Cortajarena, Aitziber L.
    [J]. CHEMICAL COMMUNICATIONS, 2023, 59 (32) : 4754 - 4757
  • [9] Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
    Bergamo, Alberta
    Sava, Gianni
    [J]. DALTON TRANSACTIONS, 2011, 40 (31) : 7817 - 7823
  • [10] Novel metal-based anticancer drugs: a new challenge in drug delivery
    Laine, Anne-Laure
    Passirani, Catherine
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (04) : 420 - 426